Clinical Trial Update: Study of Depression-Ketamine-Brain Function [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ketamine's effects on brain function in major depressive disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Markus KOSEL | Conditions: Major Depression | Phase 2 | Status: TERMINATED